REGISTER NOW



WEBINAR OVERVIEW

eConsent is one of many emerging technologies to enter the clinical trial landscape. While uncertainties follow new innovations, learning from the experiences of industry peers can help assess real and perceived complexity with factors such as global regulations, stakeholder buy-in, change management, and technology selection and delivery. We set out to obtain a global perspective into the industry’s current experience with and future intentions for eConsent use.

In late 2019, we conducted a survey of clinical researchers at sponsor and CRO organizations who had experience planning or implementing eConsent. 



Register for the Webinar

eConsent is one of many emerging technologies to enter the clinical trial landscape. While uncertainties follow new innovations, learning from the experiences of industry peers can help assess real and perceived complexity with factors such as global regulations, stakeholder buy-in, change management, and technology selection and delivery. We set out to obtain a global perspective into the industry’s current experience with and future intentions for eConsent use.

In late 2019, we conducted a survey of clinical researchers at sponsor and CRO organizations who had experience planning or implementing eConsent.

In this webinar, join the Signant survey architects as they review the findings from global respondents on eConsent:
  • Uptake rates by study phase
  • Solution providers, including satisfaction with their service and delivery
  • Features that impact patient comprehension and engagement
  • Integration with other eClinical systems
  • Deployment in clinical trials
  • Challenges and areas to improve
  • Business drivers and selection preferences
  • Future of eConsent and global adoption rates
Register for this webinar to get the who, what, when, where and why on effectively implementing electronic informed consent in global clinical trials.



PRESENTER

Neetu-Pundir.jpg
Neetu Pundir
Director, Go To Market Strategy - Product Management
Signant Health

Neetu Pundir is an experienced product and brand manager with prior professional experiences across the globe in the healthcare and life sciences industry, working for companies such as Johnson & Johnson, BIOTRONIK Medical Devices, Henry Schein, and eResearch Technology. As the Go To Market Director at Signant Health, Neetu manages the product strategy for the company’s electronic consent solution TrialConsent®. Neetu has a Master’s in Business Administration with degrees from Northwestern University, USA and the University of New South Wales, Australia.

mika.jpg
Mika Lindroos
Director, Product Management
Signant Health

Mika Lindroos is the Director of Product Management and an eConsent expert at Signant Health, and he says he is most at home where technology meets humanity. With over 24 years of experience in software product management in the global environment, Mika’s breadth of experience spans from product and portfolio management, strategy and business development, and heading a product line at Nokia to revenue and business relationship development at Digia Plc. Mika is a specialist in developing and managing relationships both internal and external to his organization, as evidenced by his varied roles in team motivation, change management, as well as customer relationship development.